[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,111,382
  • Shares Outstanding, K 42,891
  • Annual Sales, $ 3,183 M
  • Annual Income, $ 1,335 M
  • EBIT $ 1,436 M
  • EBITDA $ 1,521 M
  • 60-Month Beta 0.59
  • Price/Sales 7.18
  • Price/Cash Flow 16.16
  • Price/Book 3.57

Options Overview Details

View History
  • Implied Volatility 32.86% (-1.21%)
  • Historical Volatility 19.81%
  • IV Percentile 17%
  • IV Rank 5.76%
  • IV High 92.62% on 08/25/25
  • IV Low 29.21% on 12/05/25
  • Expected Move (DTE 13) 27.57 (5.12%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 154
  • Volume Avg (30-Day) 1,970
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 44,721
  • Open Int (30-Day) 18,068
  • Expected Range 511.27 to 566.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $6.55
  • Number of Estimates 6
  • High Estimate $7.48
  • Low Estimate $4.40
  • Prior Year $7.16
  • Growth Rate Est. (year over year) -8.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
490.80 +9.79%
on 08/05/26
563.24 -4.33%
on 07/08/26
-24.86 (-4.41%)
since 07/07/26
3-Month
490.80 +9.79%
on 08/05/26
584.71 -7.84%
on 05/13/26
-30.34 (-5.33%)
since 05/07/26
52-Week
292.34 +84.32%
on 08/12/25
609.35 -11.57%
on 05/06/26
+239.42 (+79.96%)
since 08/07/25

Most Recent Stories

More News
UTHR Q2 2026 Deep Dive: Product Pipeline Developments Offset Competitive Pressures

UTHR Q2 2026 Deep Dive: Product Pipeline Developments Offset Competitive Pressures

UTHR : 538.84 (+1.11%)
United Therapeutics (NASDAQ:UTHR) Surprises With Q2 CY2026 Sales

United Therapeutics (NASDAQ:UTHR) Surprises With Q2 CY2026 Sales

UTHR : 538.84 (+1.11%)
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 538.84 (+1.11%)
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2026. Total revenues in the second quarter...

UTHR : 538.84 (+1.11%)
United Therapeutics Reports Tomorrow With Analysts Bracing for Another Estimate Miss

Barchart Research What to Expect from UTHR Earnings UTHR Generated August 4, 2026 Current Price $518.68 EPS Estimate $$6.82 Consensus Rating Moderate Buy Average Move 6.67% United Therapeutics Reports...

UTHR : 538.84 (+1.11%)
Earnings To Watch: United Therapeutics (UTHR) Reports Q2 Results Tomorrow

Earnings To Watch: United Therapeutics (UTHR) Reports Q2 Results Tomorrow

UTHR : 538.84 (+1.11%)
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet

The long-term, pivotal, phase 3 ADVANCE OUTCOMES study of ralinepag in predominantly pre-treated patients with pulmonary arterial hypertension ( PAH ) met its...

UTHR : 538.84 (+1.11%)
United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that the company’s Board of Directors appointed Victor Dzau, M.D. , ...

UTHR : 538.84 (+1.11%)
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will report its second quarter 2026 financial results in a press release that will be issued on Wednesday, August...

UTHR : 538.84 (+1.11%)
BETA Technologies and Multistate Collaborative Complete First Operational Flights of the U.S. DOT and FAA's eVTOL Integration Pilot Program

The flights carried manufactured organs, being developed by United Therapeutics The flights are also the first in a series of use cases that will touch at least 26 states...

UTHR : 538.84 (+1.11%)
BETA : 23.51 (+3.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 561.50
2nd Resistance Point 551.27
1st Resistance Point 545.05
Last Price 538.84
1st Support Level 528.60
2nd Support Level 518.37
3rd Support Level 512.15

See More

52-Week High 609.35
Last Price 538.84
Fibonacci 61.8% 488.25
Fibonacci 50% 450.84
Fibonacci 38.2% 413.44
52-Week Low 292.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.